These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23138851)

  • 41. Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy.
    Alavi MV; Fuhrmann N; Nguyen HP; Yu-Wai-Man P; Heiduschka P; Chinnery PF; Wissinger B
    Exp Neurol; 2009 Dec; 220(2):404-9. PubMed ID: 19815013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets.
    Chen J; Riazifar H; Guan MX; Huang T
    Stem Cell Res Ther; 2016 Jan; 7():2. PubMed ID: 26738566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inherited mitochondrial optic neuropathies.
    Yu-Wai-Man P; Griffiths PG; Hudson G; Chinnery PF
    J Med Genet; 2009 Mar; 46(3):145-58. PubMed ID: 19001017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.
    Sarzi E; Seveno M; Angebault C; Milea D; Rönnbäck C; Quilès M; Adrian M; Grenier J; Caignard A; Lacroux A; Lavergne C; Reynier P; Larsen M; Hamel CP; Delettre C; Lenaers G; Müller A
    Hum Mol Genet; 2016 Jun; 25(12):2539-2551. PubMed ID: 27260406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.
    Heiduschka P; Schnichels S; Fuhrmann N; Hofmeister S; Schraermeyer U; Wissinger B; Alavi MV
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1424-31. PubMed ID: 19834041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. OPA1 haploinsufficiency induces a BNIP3-dependent decrease in mitophagy in neurons: relevance to Dominant Optic Atrophy.
    Moulis MF; Millet AM; Daloyau M; Miquel MC; Ronsin B; Wissinger B; Arnauné-Pelloquin L; Belenguer P
    J Neurochem; 2017 Feb; 140(3):485-494. PubMed ID: 27861891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eight human OPA1 isoforms, long and short: What are they for?
    Del Dotto V; Fogazza M; Carelli V; Rugolo M; Zanna C
    Biochim Biophys Acta Bioenerg; 2018 Apr; 1859(4):263-269. PubMed ID: 29382469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
    Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
    Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing Opa1 expression.
    Pang Y; Qin M; Hu P; Ji K; Xiao R; Sun N; Pan X; Zhang X
    Int J Mol Med; 2020 Nov; 46(5):1707-1720. PubMed ID: 32901846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Pattern of Retinal Ganglion Cell Loss in OPA1-Related Autosomal Dominant Optic Atrophy Inferred From Temporal, Spatial, and Chromatic Sensitivity Losses.
    Majander A; João C; Rider AT; Henning GB; Votruba M; Moore AT; Yu-Wai-Man P; Stockman A
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):502-516. PubMed ID: 28125838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sustained intracellular calcium rise mediates neuronal mitophagy in models of autosomal dominant optic atrophy.
    Zaninello M; Palikaras K; Sotiriou A; Tavernarakis N; Scorrano L
    Cell Death Differ; 2022 Jan; 29(1):167-177. PubMed ID: 34389813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress.
    Lee H; Smith SB; Sheu SS; Yoon Y
    J Biol Chem; 2020 May; 295(19):6543-6560. PubMed ID: 32245890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer.
    Aijaz S; Erskine L; Jeffery G; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1667-73. PubMed ID: 15161824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms.
    Landes T; Emorine LJ; Courilleau D; Rojo M; Belenguer P; Arnauné-Pelloquin L
    EMBO Rep; 2010 Jun; 11(6):459-65. PubMed ID: 20436456
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Cartes-Saavedra B; Lagos D; Macuada J; Arancibia D; Burté F; Sjöberg-Herrera MK; Andrés ME; Horvath R; Yu-Wai-Man P; Hajnóczky G; Eisner V
    Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2207471120. PubMed ID: 36927155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondrial dynamics and disease, OPA1.
    Olichon A; Guillou E; Delettre C; Landes T; Arnauné-Pelloquin L; Emorine LJ; Mils V; Daloyau M; Hamel C; Amati-Bonneau P; Bonneau D; Reynier P; Lenaers G; Belenguer P
    Biochim Biophys Acta; 2006; 1763(5-6):500-9. PubMed ID: 16737747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure.
    Lee H; Smith SB; Yoon Y
    J Biol Chem; 2017 Apr; 292(17):7115-7130. PubMed ID: 28298442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidative insults disrupt OPA1-mediated mitochondrial dynamics in cultured mammalian cells.
    Garcia I; Innis-Whitehouse W; Lopez A; Keniry M; Gilkerson R
    Redox Rep; 2018 Dec; 23(1):160-167. PubMed ID: 29961397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis.
    Olichon A; Baricault L; Gas N; Guillou E; Valette A; Belenguer P; Lenaers G
    J Biol Chem; 2003 Mar; 278(10):7743-6. PubMed ID: 12509422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of autophagy curtails visual loss in a model of autosomal dominant optic atrophy.
    Zaninello M; Palikaras K; Naon D; Iwata K; Herkenne S; Quintana-Cabrera R; Semenzato M; Grespi F; Ross-Cisneros FN; Carelli V; Sadun AA; Tavernarakis N; Scorrano L
    Nat Commun; 2020 Aug; 11(1):4029. PubMed ID: 32788597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.